Yu Q - Search Results

1

Prodrug Nanosensitizer Overcomes the Radiation Resistance of Hypoxic Tumor.

Qian L, Li Q, Ding Z, Luo K, Su J, Chen J, Zhu G, Gan Z, Yu Q. Qian L, et al. Among authors: yu q. ACS Appl Mater Interfaces. 2022 Dec 28;14(51):56454-56470. doi: 10.1021/acsami.2c14628. Epub 2022 Dec 16. ACS Appl Mater Interfaces. 2022. PMID: 36525559

2

Synthesis and functions of well-defined polymer-drug conjugates as efficient nanocarriers for intravesical chemotherapy of bladder cancer(a).

Yu Q, Zhang J, Zhang G, Gan Z. Yu Q, et al. Macromol Biosci. 2015 Apr;15(4):509-20. doi: 10.1002/mabi.201400416. Epub 2014 Dec 12. Macromol Biosci. 2015. PMID: 25504255

3

Polymer-Doxorubicin Conjugate Micelles Based on Poly(ethylene glycol) and Poly(N-(2-hydroxypropyl) methacrylamide): Effect of Negative Charge and Molecular Weight on Biodistribution and Blood Clearance.

Yu Q, Wei Z, Shi J, Guan S, Du N, Shen T, Tang H, Jia B, Wang F, Gan Z. Yu Q, et al. Biomacromolecules. 2015 Sep 14;16(9):2645-55. doi: 10.1021/acs.biomac.5b00460. Epub 2015 Aug 4. Biomacromolecules. 2015. PMID: 26133354

4

Polymeric Micelles with Uniform Surface Properties and Tunable Size and Charge: Positive Charges Improve Tumor Accumulation.

Shen T, Guan S, Gan Z, Zhang G, Yu Q. Shen T, et al. Among authors: yu q. Biomacromolecules. 2016 May 9;17(5):1801-10. doi: 10.1021/acs.biomac.6b00234. Epub 2016 Apr 4. Biomacromolecules. 2016. PMID: 27008333

5

Efficient Tumor Accumulation, Penetration and Tumor Growth Inhibition Achieved by Polymer Therapeutics: The Effect of Polymer Architectures.

Shen T, Xu X, Guo L, Tang H, Diao T, Gan Z, Zhang G, Yu Q. Shen T, et al. Among authors: yu q. Biomacromolecules. 2017 Jan 9;18(1):217-230. doi: 10.1021/acs.biomac.6b01533. Epub 2016 Dec 20. Biomacromolecules. 2017. PMID: 27997126

6

Positively Charged Combinatory Drug Delivery Systems against Multi-Drug-Resistant Breast Cancer: Beyond the Drug Combination.

Yan X, Yu Q, Guo L, Guo W, Guan S, Tang H, Lin S, Gan Z. Yan X, et al. Among authors: yu q. ACS Appl Mater Interfaces. 2017 Mar 1;9(8):6804-6815. doi: 10.1021/acsami.6b14244. Epub 2017 Feb 16. ACS Appl Mater Interfaces. 2017. PMID: 28185449

7

CD44-Targeted Facile Enzymatic Activatable Chitosan Nanoparticles for Efficient Antitumor Therapy and Reversal of Multidrug Resistance.

Zhang X, He F, Xiang K, Zhang J, Xu M, Long P, Su H, Gan Z, Yu Q. Zhang X, et al. Among authors: yu q. Biomacromolecules. 2018 Mar 12;19(3):883-895. doi: 10.1021/acs.biomac.7b01676. Epub 2018 Feb 14. Biomacromolecules. 2018. PMID: 29401378

8

Tumor Specific and Renal Excretable Star-like Triblock Polymer-Doxorubicin Conjugates for Safe and Efficient Anticancer Therapy.

Tang H, Zhang J, Tang J, Shen Y, Guo W, Zhou M, Wang R, Jiang N, Gan Z, Yu Q. Tang H, et al. Among authors: yu q. Biomacromolecules. 2018 Jul 9;19(7):2849-2862. doi: 10.1021/acs.biomac.8b00425. Epub 2018 May 21. Biomacromolecules. 2018. PMID: 29742345

9

Shell-Sheddable Poly(N-2-hydroxypropyl methacrylamide) Polymeric Micelles for Dual-Sensitive Release of Doxorubicin.

Zhang J, Tang H, Shen Y, Yu Q, Gan Z. Zhang J, et al. Among authors: yu q. Macromol Rapid Commun. 2018 Oct;39(20):e1800139. doi: 10.1002/marc.201800139. Epub 2018 May 16. Macromol Rapid Commun. 2018. PMID: 29770519

10

Time-dependently slow-released multiple-drug eluting external sheath for efficient long-term inhibition of saphenous vein graft failure.

Zhang Y, Fang Q, Niu K, Gan Z, Yu Q, Gu T. Zhang Y, et al. Among authors: yu q. J Control Release. 2019 Jan 10;293:172-182. doi: 10.1016/j.jconrel.2018.12.001. Epub 2018 Dec 4. J Control Release. 2019. PMID: 30521829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,745 results

Search Page

Filters